Interleukin-12 Antagonist

Name
Interleukin-12 Antagonist
Accession Number
DBCAT003459  (DBCAT004458)
Description

Not Available

Drugs
DrugDrug Description
UstekinumabA targeted antibody therapy used to manage inflammatory conditions such as plaque psoriasis, psoriatic arthritis, Crohn's Disease, and ulcerative colitis.
Drugs & Drug Targets
DrugTargetType
UstekinumabInterleukin-12 subunit betatarget
UstekinumabInterleukin-23target